Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer

NCT00005993 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

OTHER

Sponsor class

Conditions

Breast Cancer
Lymphoma

Interventions

DRUG: aldesleukin
DRUG: filgrastim
DRUG: recombinant human stem cell factor
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]